Correlation Between Development Technologies and BioNTech
Can any of the company-specific risk be diversified away by investing in both Development Technologies and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Development Technologies and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Development Technologies Corp and BioNTech SE, you can compare the effects of market volatilities on Development Technologies and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Development Technologies with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Development Technologies and BioNTech.
Diversification Opportunities for Development Technologies and BioNTech
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Development and BioNTech is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Development Technologies Corp and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Development Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Development Technologies Corp are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Development Technologies i.e., Development Technologies and BioNTech go up and down completely randomly.
Pair Corralation between Development Technologies and BioNTech
Given the investment horizon of 90 days Development Technologies Corp is expected to generate 4.57 times more return on investment than BioNTech. However, Development Technologies is 4.57 times more volatile than BioNTech SE. It trades about 0.23 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.18 per unit of risk. If you would invest 625.00 in Development Technologies Corp on October 15, 2024 and sell it today you would earn a total of 275.00 from holding Development Technologies Corp or generate 44.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Development Technologies Corp vs. BioNTech SE
Performance |
Timeline |
Development Technologies |
BioNTech SE |
Development Technologies and BioNTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Development Technologies and BioNTech
The main advantage of trading using opposite Development Technologies and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Development Technologies position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.The idea behind Development Technologies Corp and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
BioNTech vs. Novavax | BioNTech vs. Ginkgo Bioworks Holdings | BioNTech vs. Crispr Therapeutics AG | BioNTech vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |